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PDGF-mediated activation of phosphatidylinositol 3 kinase in human
mesangial cells. Platelet-derived growth factor (PDGF) stimulates mito-
genesis and exerts other biologic activities in glomerular mesangial
cells. The precise mechanism of PDGF-induced mitogenesis in these
cells is not clear. The activation of a signal transducing enzyme,
phosphatidylinositol 3 kinase (P1 3 kinase) is associated with mitogen-
esis. Activation of P1 3 kinase results from stimulation of tyrosine
kinase and G-protein-coupled classes of receptors. The synthesis of D3
phosphorylated inositides, the products of this enzymatic reaction, in
non-nucleated cells such as blood platelets is dependent upon protein
kinase C activation and G-proteins. We studied the activation of P1 3
kinase in response to PDGF in human glomerular mesangial cells. Using
a P1 3 kinase 85 kD subunit specific antibody, we detected mesangial
cell P1 3 kinase protein as 110 and 85 kD heterodimer. PDGF stimulated
P1 3 kinase activity in antiphosphotyrosine immunoprecipitates in a
dose-dependent manner showing maximum activation at 12 ng/ml. The
antiphosphotyrosine associated P1 3 kinase activity showed biphasic
kinetics with a fast peak within two minutes followed by a second peak
at 10 minutes. Antiphosphotyrosine and P1 3 kinase immunoprecipita-
tion studies indicated the association of the 85 kD P1 3 kinase subunit
with PDGFR. Direct immunoprecipitation with PDGFR /3 antibody
showed the association of P1 3 kinase activity with the PDGF-receptor.
The isoquinoline sulfonyl piperazine compound H7 at concentrations
that inhibit PDGF-stimulated PKC activity had no effect on PDGF-
stimulated P1 3 kinase activity in antiphospotyrosine immunopreci-
pates. These data indicate that P13 kinase activation is insensitive to
PKC. Treatment of mesangial cells with pertussis toxin at concentra-
tions that partially inhibited PDGF-induced DNA synthesis in human
mesangial cells did not inhibit PDGF-induced P1 3 kinase activation.
These data indicate that PDGF activates P1 3 kinase in mesangial cells
and that pertussis toxin-sensitive G-proteins are not involved in P1 3
kinase activation. The data further dissociate activation of P1 3 kinase
from mitogenesis in human mesangial cells.
The glomerular microvascular bed of the human kidney
represents a heterogeneous population of cells and is a major
target in various kidney diseases. Glomerular hypercellularity
occurs because of infiltration by inflammatory cells as well as
proliferation of intrinsic glomerular cells including mesangial,
epithelial and endothelial cells. During glomerular injury plate-
lets and monocyte/macrophages are frequently found in the
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mesangial area. Platelet-derived growth factor (PDGF), a major
cytokine released by these cells, is the most potent mitogen for
mesangial cells [1—5]. PDGF also stimulates contraction and
directed migration of mesangial cells [2—51. In several experi-
mental models of renal injury, mesangial cell proliferation is
accompanied by increased expression of PDGF and PDGF /3
receptor [3, 4].
Two different PDGF receptors, PDGFR a and f3, with defined
high-afilnity ligand binding capacities have been characterized.
These receptors are transmembrane glycoproteins with split
cytoplasmic tyrosine kinase domain [6]. Binding of PDGF to its
cognate receptor stimulates dimerization of the receptor mole-
cule on plasma membrane with increase in the intrinsic tyrosine
kinase activity of the cytoplasmic domain [7—9]. Several sub-
strate protein molecules for receptor tyrosine kinases have
recently been identified. Thus, activated PDGFR phosphory-
lates phospholipase Cyl (PLC)'!) [10, 11], GTPase activating
protein (GAP), [12] and phosphatidylinositol 3 kinase (P1 3
kinase) at tyrosine residues [13]. Each of these substrate
molecules has SH2 domains which are involved in physical
association of these proteins with activated PDGFR [14, 15].
Thus, tyrosine phosphorylation and activation ofPLCyl results
in phosphatidylinositol 4,5-bisphosphate hydrolysis in the
plasma membrane to produce inositol 1 ,4,5-trisphosphate (1P3)
and diacyiglycerol (DAG) [11, 16]. 1P3 releases intracellular
Ca2 while DAG stimulates protein kinase C (PKC) [17]. The
addition of PDGF to mesangial cells strongly stimulates phos-
phoinositide turnover and an increase in intracellular Ca2 [2].
We have recently shown that PDGF activates PKC a in human
mesangial cells and that inhibition of PKC activity by the potent
PKC inhibitor, isoquinoline sulfonyl piperazine compound H7
blocks the mitogenic effect of PDGF [18].
Another potential signal transduction pathway engaged by
PDGF receptor activation is the P1 3 kinase. This enzyme
produces D-3 phosphorylated inositides in the cells [19]. The
biological functions of these D-3 phosphoinositides are not yet
known. P1 3 kinase is activated in different cells transformed by
tyrosine kinase oncogenes and polyoma virus middle T antigen
[20—22]. Nontyrosine kinase receptor agonists such as thrombin
and interleukin 2 also stimulate P1 3 kinase to produce D3
phosphoinositides [23—25]. These observations indicated that P1
3 kinase may play important roles in various biological pro-
cesses in diverse cell types. In immortalized and receptor
38 Choudhu,y er a!: PDGF and phosphatidylinosito! 3 kinase
transfected cells, P1 3 kinase is associated with PDGFR in a
PDGF dependent manner [26]. A deletion mutant of PDGFR
that does not allow association of PT 3 kinase with the receptor
is mitogenically inactive, suggesting a role for this enzyme in
PDGF mitogenic signaling [26, 27]. Since PDGF is released in
the microenvironment of the mesangium during glomerular
inflammation and is a potent mitogen for mesangial cells, we
studied the activation of P1 3 kinase in these cells in response to
PDGF. We identified P1 3 kinase as a heterodimer of 110 and 85
kD in human mesangial cells. This enzyme is activated by
PDGF in a dose and time dependent manner. The enzyme is
tyrosine phosphorylated and associated with activated PDGFR
in these cells. PDGF-induced PKC activity and pertussis toxin
(PTX)-sensitive G-proteins are not obligatory for PDGF-in-
duced P1 3 kinase activation in human mesangial cells.
Methods
Materials
Fetal calf serum and tissue culture materials were obtained
from Gibco (Grand Island, New York, USA). Phosphatidy-
linositol and phosphatidylinositol 4 phosphate were purchased
from Sigma (St. Louis, Missouri, USA). H7 was obtained from
Calbiochem (La Jolla, California, USA). Recombinant PDGF
BB homodimer was obtained from Amgen (Thousand Oaks,
California, USA). All radioactive materials were obtained from
NEN (Boston, Massachusetts, USA). Partisil 10 SAX HPLC
column was purchased from Phenomenex (Rancho Paolos
Verdes, California, USA). Human PDGFR /3 monoclonal anti-
body was obtained from Genzyme. Antiphosphotyrosine anti-
body covalently coupled to agarose beads was from Oncogene
Science. Western blotting kit (ECL western blotting protocols)
was purchased from Amersham (Arlington Heights, Illinois,
USA). P1 3 kinase antibody was obtained from UBI. All other
reagents were analytical grade.
Human glomerular mesangial cell culture
Isolation and detailed characterization of normal human
kidney mesangial cells were described elsewhere [2]. The cells
were grown in Waymouth's medium with 17% fetal calf serum
and were made quiescent by serum starvation for 48 hours in
the same medium. For H7 experiments, the cells were treated
with 30 jsri H7 for 18 hours before use. We have recently shown
that this concentration of H7 completely abolished PDGF-
induced PKC activity and DNA synthesis in these cells [18]. In
all experiments, cells were stimulated with PDGF BB ho-
modimer which interacts with /3 as well as a receptors. Since
mesangial cells express tenfold more PDGF /3 than a receptors
[5], the effects of PDGF BB homodimer used in these experi-
ments are predominantly due to activation of the /3 receptor.
Metabolic labeling and immunoprecipitation
Confluent mesangial cells were starved in serum-free methi-
onine-free medium for three hours and then incubated in the
same medium containing 1% dialyzed serum plus 50 pCi/mi
35S-methionine for 12 hours. The cells were lysed in RIPA
buffer (20 m'vi Tris HCI, pH 7.5, 150 mr'vi NaCL, 5 mM EDTA, 1%
NP-40, 1 m Na3VO4, 1 mri PMSF and 0.1% aprotinin) for 30
minutes at 4°C. After centrifugation at 10,000 X g for 30 minutes
at 4°C, P1 3 kinase antibody was added to the cleared superna-
tant and incubated on ice for 30 minutes. Fifteen microliters
Protein A sepharose beads (50% vol/vol slurry) were added and
incubated at 4°C on a rocking platform for two hours. The beads
were washed twice with RIPA buffer, twice with buffer A (0.5 M
LiC1, 0.1 M Tris-HC1, pH 7.5, 1 m Na3VO4), once again with
RIPA, and finally once with 50 mM Tris-HC1 pH 7.4. The beads
were then resuspended in SDS sample buffer. The labeled
proteins were separated on 7.5% polyacrylamide gel. The gel
was fluorographed using PPOIDMSO, dried and exposed to
X-OMAT AR film.
P13 kinase assay
Quiescent mesangial cells were stimulated with PDGF, and
the cleared cell extract was prepared in RIPA buffer as de-
scribed above. Protein concentration was measured in the cell
lysate. Equivalent amounts of proteins from control and PDGF
stimulated cells were immunoprecipitated with either a mono-
clonal antiphosphotyrosine antibody, human PDGFR/3 mono-
clonal antibody or anti-PI 3 kinase polyclonal antibody. Sev-
enty-five micrograms of antiphosphotyrosine antibody coupled
to the agarose beads, 15 pg of PDGFRI3 antibody and 3 d of P1
3 kinase antibody (sufficient for 700 g of cell lysate) were used
to immunoprecipitate the mesangial cell lysate. Use of these
antibodies to immunoprecipitate enzymatically active P1 3
kinase indicate that they do not inhibit the enzymatic activity of
the protein. After immunoprecipitation, the immunobeads were
washed three times with RIPA, once with PBS, once with
Buffer A, once with double distilled water and finally with
buffer B (0.1 M NaC1, 0.5 m EDTA, 20 mrvi Tris NaCI, pH 7.5).
P1 3 kinase assay was performed on the beads directly as we
described previously [28]. Briefly, the immunoprecipitates were
resuspended in 50 ,sl of P1 3 kinase assay buffer (20 mM
Tris-HC1, pH 7.5, 0.1 M NaC1 and 0.5 mM EGTA); 0.5 d of 20
mg/mi P1 was added and incubated at 25°C for 10 minutes. Then
1 d of 1 M MgC12 and 10 pCi of 732P-ATP were added simulta-
neously. The reaction mixture was further incubated at 25°C for
an additional 10 minutes. The reaction was stopped with 150 pi
of a mixture of chloroform, methanol and 11.6 N HC1 at a ratio
of 50:100:1. Then 100 l of chloroform were added. After
extraction, the organic layer was washed once with 80 d of a
mixture of methanol and 1 N HCI (1:1). The reaction product
was dried under a stream of nitrogen, dissolved in 10 j.d of
chloroform containing P1 4 P as standard and separated by thin
layer chromatography and developed with CH Cl3/MeOH/28%
NH4OH/H20 (129:114:15:21). The spots were visualized by
autoradiography. Cold P1-4-P standard was visualized by spray-
ing the TLC plates with 2-p-toluidinyl-naphthalene-6-sulfonic
acid and illumination with UV light. Spots were scraped and
counted.
Analysis of PIP product by HPLC
Autoradiograms of TLC plates were used to locate the PIP
spots of the PT 3-kinase reaction products. The spots were
scraped and the lipids were deacylated as described earlier [19].
A known amount of 3H-PI-4-P was added to the eluent as an
internal standard. The lipids were deacylated in the presence of
methylamine reagent (42.5% of 25% methylamine, 45.7% meth-
anol, 11.4% n-butanol) at 53°C for 50 minutes. The silica gel
from the TLC plate was separated by centrifugation (1610 X g
for 10 mm). The glycerophosphoinositide samples were dried in
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vaduo, washed with water and dried again. The dried material
was dissolved in 1 ml distilled water containing known amounts
of AMP, ADP and ATP as absorbance standards. The sample
was filtered (0.45 m Millipore Type HV filter) and analyzed on
a Waters HPLC system (dual M45 pumps, M721 system con-
troller, Model 441 absorbance detector, and M730 data module)
using a 25 cm X 0.45 cm Partisil 10 SAX column. Milli-Q system
purified water was used throughout. Pump A delivered H20 and
pump B buffer was 1.9 M (NH4)2HP04 pH 3.8, made using
HPLC grade (NH4)2HP04. The gradient was 0% Buffer B for 10
minutes to 13% Buffer B over 60 minutes, then to 53% Buffer B
over 50 minutes. The absorbance at 254 nm of the HPLC
effluent was measured to detect the adenine nucleotide internal
standards. The radioactivity of the eluent was quantified by an
on-line continuous flow scintillation detector coupled to an IBM
PC XT-type computer for data collection and analysis.
Measurement of DNA synthesis
DNA synthesis was measured by 3H-thymidine incorporation
essentially as described before [1, 18].
Immunokinase assay
The tyrosine kinase assay was performed directly on the
immunoprecipitates as described previously [28].
Western blotting
Immunoprecipitated samples or cell lysates were analyzed on
SDS gel. The separated proteins were electrophoretically trans-
ferred to polyvinyl membrane. The blocking of the blot was
performed in 2% BSA prepared in PBS containing 0.1% Tween
20 (PBS-T) for one hour at room temperature on an orbital
shaker. The membrane was washed two times for 15 minutes
and twice for five minutes with PBS-T. The membrane was then
incubated with anti-PI 3 kinase antibody (1:5000 dilution) for
one hour at room temperature on a roller shaker. The mem-
brane was washed four times with PBS-T. The membrane was
then incubated with horseraddish peroxidase conjugated goat
anti-rabbit IgG for 60 minutes. The excess secondary antibody
was washed with PBS-T and the signal was developed with
ECL reagent.
Results
1dentfication of P13 kinase in human mesangial cells
P1 3 kinase has recently been purified from bovine brain and
rat liver [29, 30]. The enzyme from both sources appears as two
distinct bands of 110 and 85 kD in denaturing SDS gel. To
identify P1 3 kinase in human mesangial cells, confluent cultures
were labeled with 35S-methionine and the cleared cell lysate
was immunoprecipitated with a polyclonal anti 85 kD subunit
antibody. The immunoprecipitates were analyzed on SDS poly-
acrylamide gel (Fig. I). Two major bands of 110 and 85 kD were
detected (lane 1, indicated by arrows). These bands were absent
in precipitates treated with nonimmune serum (lane 2). These
data indicate that in human mesangial cells, P1 3 kinase het-
erodimers correspond to those reported in rat liver and bovine
brain. The anti-PI 3 kinase polyclonal antibody also precipitated
proteins of about 92 kD and a triplet between 50 and 55 kD. The
specificity and identity of these proteins remain to be deter-
mined.
Fig. 1. identification of P13 kinase in human mesangial cells. Confluent
mesangial cells were labeled with 35S-methionine and the cell lysate was
immunoprecipitated with either anti-PI 3 kinase 85 kD subunit antibody
or non-immune serum as described in Methods. Five x 106 TCA
precipitable counts of each of the immunoprecipitates were analyzed on
7.5% polyacrylamide gel. Lane 1, immune serum and Lane 2 nonim-
mune serum. Arrow indicates the 110 and 85 kD bands. Molecular
weight markers in kD are shown.
PDGF activation of P13 kinase in mesangial cells
Activated PDGFR phosphorylates P1 3 kinase at tyrosine
residues and stimulates its enzymatic activity [31]. To deter-
mine if PDGF tyrosine phosphorylates and activates P1 3 kinase
in mesangial cells, cleared lysates from control and PDGF
treated cells were immunoprecipitated with antiphosphoty-
rosine monoclonal antibody. The washed immunobeads were
assayed for P1 kinase activity using phosphatidylinositol as
substrate in the presence of y32P-ATP. The reaction products
were analyzed on silica gel 60 TLC plates. As shown in Figure
2, PDGF stimulates the production of PIP in antiphosphoty-
rosine immunoprecipitates (compare lane 2 with 1). Inclusion of
2 mM phenyl phosphate during the immunoprecipitation com-
pletely abolished the antiphosphotyrosine-associated P1 kinase
activity confirming the specificity of the antibody used. Use of
phosphoserine, a noncompeting ligand during immunoprecipi-
tation does not block the antiphosphotyrosine bound P1 kinase
activity (lanes 5 and 6). To measure the fraction of P1 3 kinase
activity that gets tyrosine phosphorylated in response to PDGF,
we stimulated mesangial cells with PDGF BB and the cell lysate
was immunoprecipitated with excess antiphosphotyrosine anti-
body. The phosphotyrosine-depleted supernatant was then fur-
ther immunoprecipitated with excess P1 3 kinase antibody and
the P1 3 kinase activity in the immunobeads was determined.
Quantitation of P1 3 P counts in the TLC spots (counts in
antiphosphotyrosine immunoprecipitates/counts in antiphos-
photyrosine immunoprecipitates and counts in anti-PI 3 kinase
immunoprecipitates) revealed that approximately 24% of total
P1 3 kinase activity was associated with phosphotyrosine con-
taining proteins (data not shown).
Authenticity of the PIP lipid product
To confirm the identity of the in vitro P1 kinase reaction
product, the 32P-labeled products on TLC plates were located
by autoradiography. The spots were scraped, mixed with stan-
dard 3H-phosphatidylinositol-4-phosphate and deacylated. The
resulting glycerophosphoinositides were analyzed by HPLC as
• S PIP
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Fig. 2. PDGF stimulation of phosphotyrosine-associated P13 kinase activity. Quiescent confluent mesangial cells were stimulated with PDGF
for 10 minutes. The cell lysate was immunoprecipitated with antiphosphotyrosine antibody in the presence and absence of 2 mM phenyiphosphate
or phosphoserine. The immunobeads were used to assay P1 3 kinase activity as described in Methods. Lanes 1, 3, 5 and 7 are unstimulated. Lanes
2, 4, 6 and 8 are stimulated with PDGF. Lanes 3 and 4 are in the presence of phenyiphosphate. Lanes 5 and 6 are in the presence of phosphoserine.
Lanes 7 and 8 are lysates immunoprecipitated with nonimmune serum. PIP indicates the position of standard P1-4-P.
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Fig. 3. HPLC analysis of P1 kinase reaction product. Antiphosphoty-
rosine immunoprecipitates from control and PDGF-stimulated quies-
cent mesangial cells were assayed for P1 kinase activity and the reaction
products were separated on TLC plate. 32P-PIP spots were scraped off
after localization by autoradiography. A known amount of 3H-PI-4-P
was added, lipids were deacylated and the water soluble glycerophos-
phoinositides were analyzed by HPLC using a partisil 10 SAX column
as described in Methods. Squares and lines indicate 32P- and 3H-counts,
respectively. Closed squares are in the presence and open squares are
in the absence of PDGF.
described in the Methods (Fig. 3). It has been shown previously
that in this chromatographic separation Grolns-3-P elutes about
three minutes earlier than Grolns-4-P [28]. The profiles of
32ppJ kinase reaction products that eluted before the 3H-
labeled glycero 4 phosphoinositide in mesangial cells are iden-
tical to those reported earlier [28]. This indicates that the
product of the antiphosphotyrosine-associated P1 kinase reac-
tion is authentic P1-3-P.
Dose response and kinetics of P13 kinase activation
To determine the dose responsiveness to PDGF, quiescent
mesangial cells were stimulated with different concentrations of
growth factor. The cell lysate was immunoprecipitated with
antiphosphotyrosine antibody and assayed for P1 3 kinase
activity in vitro. The data show that 2 nglml of PDGF stimulated
21.6-fold increase in P1-3-P production (Fig. 4A, compare lane
2 with 1). At 12 nglml the stimulation reached a maximum of 42-
fold (Fig. 4A, lane 7 and Fig. 4B). To study the kinetics of
activation of this enzyme, quiescent cells were stimulated with
12 nglml PDGF for different time periods. The antiphosphoty-
rosine immunoprecipitates were assayed for P1 3 kinase activity
and the reaction products were analyzed on TLC. The 32P-PI-
3-P spots were scraped and counted (Fig. 5). The data show that
PDGF stimulates P1 3 kinase activity in a biphasic manner in
antiphosphotyrosine immunoprecipitates. A fast peak appeared
at two minutes followed by a drop in activity and a second peak
at 10 minutes. These data indicate that the PDGF-stimulated
antiphosphotyrosine-associated P1 3 kinase activity is transient
in human mesangial cells.
a-
c)
a-
ci,
a-0
a-
a.
'A . S • Spip'.'AS
I.
2
B
15
12
0)
0
3
0
I.....
3 4 5 6 7 8
//
/
.
S /
•\\/
S
S
I
0 5 10 15 20
Choudhury et al: PDGF and phosphatidylinositol 3 kinase 41
PDGF, ng/ml
Fig. 4. PDGF concentration dependence of P13 kinase activation in human mesangial cells. Quiescent mesangial cells were stimulated with
different concentrations of PDGF and the cell lystates were immunoprecipitated with antiphosphotyrosine antibody. The immunobeads were
assayed for P1 3 kinase activity. Lanes 1 through 8 were: unstimulated, 2 nglml, 4 nglml, 6 nglml, 8 ng/ml, 10 ng/ml, 12 ng/ml and 15 ng/ml
respectively. PIP indicates the P1-4-P standard position. (A) Autoradiography of the TLC analysis. (B) Quantitation of P1-3-P spots shown in A.
Similar dip in activity was observed in an independent experiment.
Association of P13 kinase with activated PDGFR in
mesangial cells
The 85 kD subunit of P1 3 kinase is tyrosine phosphorylated
in oncogene transformed cells [32]. To detect the tyrosine
phosphorylation of P13 kinase directly, we immunoprecipitated
control and PDGF treated mesangial cell extracts with an-
tiphosphotyrosine antibody. The immunobeads were used in a
tyrosine kinase assay in the presence of y32P-ATP. The labeled
proteins were separated on SDS gel (Fig. 6, lanes 1 and 2). The
major autophosphorylated protein is PDGFR (indicated by
open arrow). Among the other tyrosine phosphorylated pro-
teins in PDGF treated samples (lane 2) we identified an 85 kD
protein (indicated by filled arrow). To confirm that this 85 kD
protein is a part of P1 3 kinase and that it is associated with
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Fig. 5. Time course for P13 kinase activation in response to PDGF.Quiescent mesangial cells were stimulated with 12 ng/ml PDGF for
different periods of time. The antiphosphotyrosine immunoprecipitate
of each cell lysate was assayed for P1 3 kinase activity and separated on
TLC plate. P1-3-P spots were located by autoradiography, scraped off
the plate and counted. Panels A, B and C represent three independent
experiments.
PDGFR in a ligand dependent manner, we used PT 3 kinase 85
kD subunit antibody to immunoprecipitate the enzyme directly
from control and PDGF stimulated mesangial cell extracts. The
immunobeads were assayed for tyrosine kinase activity and
tyrosine phosphorylated proteins were analyzed on SDS gel
(Fig. 6, lanes 3 and 4). The 85 kD protein could be detected
(indicated by arrow) along with PDGFR (open arrow) only in
the PDGF treated sample (compare lane 4 with 3). The same 85
kD protein was also detected in PDGFR immunoprecipitates in
a PDGF-dependent manner (Fig. 6, compare lane 8 with lane 7).
These data indicate that in PDGF activated human mesangial
cells, PT 3 kinase is physically associated with the PDGFR.
To confirm this association, we immunoprecipitated PDGFR
from control and PDGF stimulated cells. The proteins were
analyzed on SDS gel. The separated proteins were immunoblot-
ted with anti-PT 3 kinase antibody. The data show that the 85 kD
P1 3 kinase subunit is associated with PDGFR in a PDGF
dependent way (Fig. 7, arrow compare lane 2 with lane 1).
Along with the 85 kD subunit, anti-PT 3 kinase antibody also
recognized another low molecular weight protein in both me-
sangial cells and rat liver extract. The identity of this band is not
clear.
To further confirm that the P1 3 kinase is physically associ-
ated with the PDGFR, we measured P1 3 kinase activity in
PDGFR immunoprecipitates from control and PDGF treated
mesangial cells. The data (Fig. 8) show that within two minutes
of PDGF addition, the PT 3 kinase activity becomes associated
with PDGFR. However, 67% of total P1 3 kinase activity is lost
at 30 minutes, suggesting that this association of PT 3 kinase
activity with PDGFR is transient.
PDGF-mediated P13 kinase is insensitive to PKC activation
We have recently shown that PDGF stimulates PKC a
activity in human mesangial cells and that inhibition of PKC
activity completely blocked PDGF-induced DNA synthesis in
these cells [18]. This suggested that PKC a may play a role in
PDGF-mediated mitogenesis in mesangial cells. Activation of
PKC in polyoma virus middle T antigen transformed cells
stimulates tyrosine phosphorylation of 85 kD subunit of P1 3
kinase and increases its activity [33]. This indicated the plausi-
ble involvement of PKC in the activation of PT 3 kinase. Since
PKC activation was associated with PDGF-induced mesangial
cell proliferation, we studied its involvement in PDGF-induced
P1 3 kinase activation. We pretreated quiescent mesangial cells
with the isoquinoline sulfonyl piperazine compound H7, a
potent inhibitor of serine threonine kinases including PKC. This
compound completely blocked PDGF-induced PKC activity
and DNA synthesis in human mesangial cells [181. Control and
PDGF stimulated cell extracts were immunoprecipitated with
antiphosphotyrosine antibody and P1 3 kinase activity was
measured. As shown in Figure 9 there is no significant decrease
in P1 3 kinase activity in H7 treated samples (compare lane 4
with lane 2). These data demonstrate that PDGF-mediated
activation of P1 3 kinase is not dependent on PKC or other
serine-threonine kinases in human mesangial cells.
Involvement of G-protein(s) in PDGF-induced DNA synthesis
and its relation to P13 kinase activation
The nonhydrolyzable guanosine nucleotide analog GTPyS
has recently been shown to stimulate D-3 phosphorylated
inositide production in platelets, suggesting a role for G-pro-
teins in the activation of P13 kinase [34]. In addition, incubation
of platelets with pertussis toxin partially inhibits D3 phosphor-
ylated inositides formation indicating G-protein involvement in
P1 3 kinase activation [351. To explore the potential involve-
ment of PTX sensitive G-protein(s) in PDGF mitogenic signal-
ing, we measured PDGF-induced DNA synthesis in the pres-
ence of this toxin. The data (Fig. 1OA) demonstrate 60%
inhibition of PDGF-stimulated DNA synthesis by 5 ng/ml PTX
indicating the requirement of a PTX-sensitive G-protein. In
contrast to its effect on DNA synthesis, PTX had no effect on P1
3 kinase activation in response to PDGF (Fig. lOB), indicating
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Fig. 6. Tyrosine phosphorylation and association of P1 3 kinase with activated PDGFR. Quiescent mesangial cells were stimulated with 12 ng/ml
PDGF for 10 minutes. Cell lysates were immunoprecipitated with antiphosphotyrosine antibody (lanes 1 and 2), P1 3 kinase 85 kD subunit antibody
(Lanes 3 and 4), nonimmune serum (lanes 5 and 6) and anti-PDGFR/3 antibody (lanes 7 and 8), respectively. The immunoprecipitates were directly
used in immunokinase assay in the presence of y32P-ATP as described before [281. Lanes 1, 3, 5 and 7 are control and Lanes 2, 4, 6 and 8 are in
the presence of PDGF. Open arrow indicates the PDGFR protein and closed arrow indicates 85 kD P1 3 kinase regulatory subunit. Molecular
weight markers are shown in kD.
that PTX-sensitive G-protein(s) are not involved in P1 3 kinase
activation in mesangial cells.
Discussion
Accumulating evidence in human and experimental animals
suggests that PDGF plays an important role in inflammatory
and proliferative glomerular diseases. Addition of PDGF to
cultured mesangial cells stimulates PLC and PLA2 activity with
concomitant increase in cytosolic calcium and activation of
Na/H antiport leading to alkalinization of the cytoplasm.
PDGF activation of other immortalized cells stimulates tyro sine
phosphorylation of a panel of substrates which include different
signal transducing proteins such as PLC)/1, GAP and P1 3
kinase [10—13]. Activation of P1 3 kinase results in the produc-
tion of D-3 phosphorylated inositides, the biological functions
of which are not yet known. However, CHO cells expressing a
PDGFR mutant deficient in PT 3 kinase activation were not
mitogenic in response to PDGF, suggesting a role for this
enzyme in PDGF mitogenic signaling [26, 271. In this study we
examined the activation of P1 3 kinase in response to PDGF in
human mesangial cells. Mesangial cell Pt 3 kinase appears as a
heterodimer of 110 and 85 kD subunits (Fig. 1). Purified PT 3
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Fig. 7. Association of P13 kinase with PDGFR. Control and PDGF-
stimulated cell lysate were immunoprecipitated with anti PDGFRI3
antibody and analyzed on SDS gel. The separated proteins were
transferred onto polyvinyl filter and immunoblotted with anti-PI 3
kinase antibody as described in materials and methods. Lane 1, control;
lane 2, PDGF stimulated; lane 3, rat liver extract. Arrow indicates 85
kD Pt 3 kinase subunit. Molecular weight markers are shown in kD.
'p
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Fig. 8. Kinetics of P13 kinase activation in PDGFR immunoprecipitates in mesangial cells. Quiescent mesangial cells were stimulated with 12
ng/ml PDGF for different periods of time and the cell lysate was immunoprecipitated with PDGFR monoclonal antibody as described in Methods.
The immunobeads were assayed for associated P1 3 kinase activity. Lanes 1, unstimulated; Lanes 2 to 6 stimulated with PDGF for2, 5, 10, 15 and
30 minutes, respectively. PIP indicates the position of P1-4-P standard.
kinase from rat liver and bovine brain [29, 30] have similar
molecular weights. Our data confirm that human mesangial cells
contain similar heterodimeric P1 3 kinase identified in bovine
and rat tissue. In the absence of PDGF, there was no detectable
activity in the antiphosphotyrosine immunoprecipitates,
whereas after PDGF treatment there was a marked increase in
the P1 3 kinase activity in the antiphosphotyrosine immunopre-
cipitates. Approximately 24% of the total PT 3 kinase activity in
PDGF treated cells was recovered in the antiphosphotyrosine
immunoprecipitates. PDGF stimulated this enzymatic activity
in a dose and time dependent manner (Figs. 4, 5). Of interest is
the biphasic nature of PDGF-induced P1 3 kinase activation. At
30 to 60 minutes, 78 to 88% of total PDGF stimulated antiphos-
photyrosine associated activity is lost (Fig. 5), suggesting the
presence of a deactivating mechanism of these signals in
mesangial cells. The P1 3 kinase enzyme was associated with
activated PDGFR in mesangial cells (Figs. 6, 7 and 8) similar to
immortalized cells or receptor transfected cells.
It has been shown that the tumor promoting phorbol ester
TPA stimulates P1 3 kinase activity and tyrosine phosphoryla-
tion of the 85 kD protein in polyomavirus middle T antigen
transformed cells [33]. This finding suggested a role for protein
kinase C in mediating the P1 3 kinase activity in these cells.
Furthermore, in platelets, the production of D3-phosphorylated
inositides has been shown to be dependent on PKC activation.
PT 3 kinase and PKC were found to be localized in a subcellular
fraction of activated platelets [35]. We have recently shown that
PDGF stimulates PKC a in human mesangial cells and that this
activity may be necessary for PDGF-induced mitogenesis in
these cells. However, the potent serine threonine kinase/PKC
inhibitor, H7, had no effect on PDGF-mediated P1 3 kinase
activity in these cells (Fig. 9) although it abolished PDGF-
induced PKC activity [18]. This observation suggests that PKC
or other serine threonine kinases interact with other signaling
pathways and do not regulate PDGF-induced P1 3 kinase
activity in mesangial cells.
PT 3 kinase has been shown to be activated by most viral
tyrosine kinase oncogenes and polyoma virus middle T antigen
[20—22]. In all of these cases, the activation is accompanied by
cell transformation. P1 3 kinase, however, can be activated by
external stimuli in certain cell types. For example, in neutro-
phils, the chemotactic peptide f-met leu phe and in blood
platelets, thrombin stimulate P1 3 kinase activity [23, 24, 36].
This suggests that this enzyme may have effects other than
mitogenesis. In human platelets, activation of G-protein(s) is
involved in D-3 phosphorylated inositide production [34], sug-
gesting that P1 3 kinase activation is dependent on G-protein(s)
in these cells. In human mesangial cells, our data show that
PDGF-stimulated DNA synthesis is partially inhibited by per-
tussis toxin indicating the involvement of a PTX-sensitive
G-protein in PDGF mitogenic signaling pathway. However,
PDGF-mediated increase in PT 3 kinase activity is not depen-
dent on PTX-sensitive 0-proteins (Fig. 10), suggesting a cell
specific role of G-proteins in P1 3 kinase activation. These data
also indicate that PTX inhibition of PDGF-induced DNA syn-
thesis does not result from inhibition of P1 3 kinase activity. It
is likely that PTX and G-proteins interact with other signaling
pathways to mediate the mitogenic effect of an activated
tyrosine kinase receptor.
The 85 kD subunit of P1 3 kinase has recently been cloned
from human, bovine and mouse [37—39]. The translated protein
from cDNA alone does not have any PT 3 kinase activity when
expressed in mammalian cells. Rather, it serves as a regulatory
subunit of the active dimeric enzyme. This subunit has two
tandem SH2 domains following a single SH3 domain. The SH2
domains have been implicated to function as an adaptor to
PIP
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Fig. 9. Effect of PKC inhibitor H7 on PDGF-
induced P13 kinase activity in human
mesangial cells. Quiescent confluent
mesangial cells were pretreated with 30 /LM
H7 for 18 hours as described [18]. The cells
were then stimulated with 12 ng/ml PDGF for
10 minutes. Antiphosphotyrosine
immunoprecipitates from cell lysate were used
for P1 3 kinase activity. Lanes 1, 3 are
control; Lanes 2, 4 are in the presence of
PDGF. Lanes 3 and 4 are pretreated with H7.
associate with tyrosine phosphorylated proteins [14, 15]. Thus
P1 3 kinase can associate with tyrosine phosphorylated acti-
vated PDGFR. In human mesangial cells, we have also detected
an association of the 85 kD protein and the P1 3 kinase activity
with PDGFR upon activation with PDGF (Figs. 6, 7 and 8). SH3
domains are found in some cytoskeletal proteins, such as
spectrin and in some proteins of budding and fisson yeast [40,
41]. It has been postulated that SH3 domain may be involved in
binding to different cytoskeletal elements. Recently an SH3
domain binding protein has been cloned and appears to be
related to the members of Rho/Rae family of small G-proteins
[42]. Moreover, Rho and Rae proteins have been shown to
control membrane ruffling, actin stress fiber formation and focal
contacts [43, 44]. Whether P1 3 kinase interacts with Rho/Rae is
not known. However, activated PT 3 kinase has been found in
the membrane fraction of human mesangial cells (Ghosh
Choudhury et al, unpublished observation). In addition to its
mitogenic effect, PDGF stimulates mesangial cell contraction
and migration during which cells change their shape to elon-
gated or spherical fusiform structures [2, 45]. It is conceivable
that treatment with PDGF results in association of assembled
cytoskeletal proteins with the SH3 domain of the P1 3 kinase.
The 110 kD subunit of P1 3 kinase has been recently cloned
[46]. When expressed independently in the absence of the 85 kD
subunit, it retains the P1 3 kinase activity indicating that this is
the catalytic subunit of the enzyme. The C-terminus of this
subunit is highly homologous to a protein in Saccharomyces
cerevisiae referred to as VPS34P. This protein has an important
role in vesicular transport and targeting of proteins to the
vacuoles for final secretion. Recently it has been reported that
VPS34P protein has P1 3 kinase activity in vitro [47]. PDGF
stimulates de novo synthesis and secretion of TGF-/3 and PDGF
itself [48, 49]. Whether P1 3 kinase has a role in targeting these
proteins through the secretory pathway is unknown at present.
PDGF-mediated P1 3 kinase activation in mesangial cells may
elicit a variety of biological responses relevant to proliferative
and nonproliferative glomerular disorders. The elucidation of
precise mechanisms of these responses requires further inves-
tigation.
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